MetLife Investment Management’s Vivid Seats SEAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,264
Closed -$134K 2913
2025
Q1
$134K Buy
2,264
+393
+21% +$31.6K ﹤0.01% 2392
2024
Q4
$173K Sell
1,871
-375
-17% -$28K ﹤0.01% 2367
2024
Q3
$166K Hold
2,246
﹤0.01% 2377
2024
Q2
$258K Buy
2,246
+264
+13% +$28.7K ﹤0.01% 2086
2024
Q1
$237K Buy
1,982
+1,225
+162% +$144K ﹤0.01% 2097
2023
Q4
$95.7K Hold
757
﹤0.01% 2626
2023
Q3
$97.2K Hold
757
﹤0.01% 2594
2023
Q2
$120K Hold
757
﹤0.01% 2575
2023
Q1
$116K Hold
757
﹤0.01% 2489
2022
Q4
$111K Hold
757
﹤0.01% 2555
2022
Q3
$116K Hold
757
﹤0.01% 2604
2022
Q2
$113K Buy
+757
New +$137K ﹤0.01% 2659

Other funds holding SEAT

MetLife Investment Management's SEAT Position: Q2 2025 in Review

MetLife Investment Management sold out of Vivid Seats (SEAT) in Q2 2025, closing a stake of 2,264 shares — an estimated $134K sold.

MetLife Investment Management first reported a position in SEAT in Q2 2022 and held it in 12 quarters. The position peaked at $258K in Q2 2024. 100 funds tracked by Wall St. Rank hold SEAT as of Q2 2025.

  • MetLife Investment Management reported no remaining Vivid Seats position as of Q2 2025 after selling out during the quarter.
  • MetLife Investment Management sold 2,264 Vivid Seats shares in Q2 2025, an estimated $134K.
  • MetLife Investment Management first reported a position in Vivid Seats in Q2 2022 and held it in 12 quarters.
  • MetLife Investment Management's Vivid Seats position peaked at $258K in Q2 2024.
  • 100 funds tracked by Wall St. Rank held Vivid Seats as of Q2 2025.

Based on MetLife Investment Management's 13F filing for Q2 2025, filed 13 Aug 2025.